(2020-01) SHENB, a manufacturer specializing in medical and beauty devices for the 21st year of its establishment "Lack of legal basis for domestic industry...
SHENB, a manufacturer specializing in medical and beauty devices for the 21st year of its establishment "Lack of legal basis for domestic industry... desperate for institutional support to open up market expansion"
“The medical device development technology of domestic companies, which started as a copy product in the past, is now lined with the products of famous overseas companies.
The market that the medical device industry is paying the most attention recently is Korea.” Seon-young Kang, CEO of SHENB, emphasized the potential of the domestic medical device industry to develop in Newspim·Monthly ANDA and Interview.
CEO Kang said, “It is judged that the product that succeeds in the Korean market is also likely to be successful in the international market.” “The status of a domestic company has increased a lot.”
SHENB, led by CEO Kang, specializes in developing and manufacturing skin medical devices and beauty devices. Founded in 1999, this year marks the 21st year.
Its flagship products include “PLADUO,” a skin treatment device that uses plasma energy, and “SOMA,” a high-frequency home care device. Long-term steady results
Regarding the secret, Mr. Kang explained, "Because XNHB releases more than one new product every year with the goal of creating female beauty."
XNB's flagship products are largely divided into medical device parts and home care beauty device parts. Pladuo, which is sold in the medical device field, uses a certain medium.
Treatment proceeds by controlling the generated plasma energy at a certain amount and interval and delivering it to the skin. Unlike laser treatment commonly performed in dermatology,
It has the advantage of not leaving a trace. SHENB is recognized for its technology and effectiveness as the world's first two plasmas are implemented in one device.
The reinforcement of the home care beauty equipment part, another flagship product, reflected a lot of CEO Kang's intention. In 2017, CEO Kang launched 'SELKIT', SHENB's own brand.
After that, he developed and sold a product called “Soma”. SOMA is a complex body manager that has the advantage of being able to use all of the high frequency, suction, and LED functions with just three buttons.
CEO Kang said, “I developed SOMA with the thought that it would be possible to make 'Nemesis', a medical device that has been steadily loved for a long time in SHENB, to be used at home.”
Said. In general, it is effective that the body manager is equipped with not only simple high frequency but also stimulation functions such as suction.
CEO Kang explained that the company's accumulated technology and know-how was backed by the miniaturization of SOMA's suction management function and enabling wireless operation.
Export performance is also steadily showing. In 2016, SHENB entered the US market with the approval of the U.S. Food and Drug Administration (FDA) for the skin treatment device 'VIVACE' using a high-frequency needle.
Vivace has been ranked No. 1 in the sales of similar equipment for two years in a row since 2018, and continues to receive awards at various awards ceremony. CEO Kang said, “More than 10 international conferences and medical devices a year.
We have been attending the exhibition to promote our products. We aim to promote the excellence of our products through continuous research and development and advance into more markets.”
Representative Kang pointed out the difficulties of the domestic beauty and medical device industry. "The beauty and medical device sector is characterized by a very limited and difficult market size."
"In particular, medical devices are difficult to put in a lot of time and manpower in the process of undergoing various examinations, experiments, and clinical trials," he said.
He said, "It takes a long time to pass the regulations, but the demands of the market are changing rapidly, and foreign competitors are rushing to market," he said.